44.7 percent of angiotensin receptor blocker initiators were continuously persistent to original drug class at three years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback